Hanne F. Harbo

Overview

Best Publications

• Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

  Stephen Sawcer;Garrett Hellenthal;Matti Pirinen;Chris C. A. Spencer

  3044
  Citations

• Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

  Ashley H. Beecham;Nikolaos A. Patsopoulos;Nikolaos A. Patsopoulos;Dionysia K. Xifara;Mary F. Davis

  1397
  Citations

• Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis

  Frida Lundmark;Kristina Duvefelt;Ellen Iacobaeus;Ingrid Kockum

  623
  Citations

• Sex and gender issues in multiple sclerosis

  Hanne F. Harbo;Ralf Gold;Mar Tintoré

  542
  Citations

• Class II HLA interactions modulate genetic risk for multiple sclerosis

  L Moutsianas;L Jostins;A H Beecham;A T Dilthey

  421
  Citations

• A high-density screen for linkage in multiple sclerosis.

  Sawcer S;Ban M;Maranian M;Yeo Tw

  418
  Citations

• The genetics of multiple sclerosis: an up-to-date review.

  Pierre-Antoine Gourraud;Hanne F. Harbo;Hanne F. Harbo;Stephen L. Hauser;Sergio E. Baranzini

  379
  Citations

• Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene.

  Eveliina Jakkula;Eveliina Jakkula;Eveliina Jakkula;Virpi Leppa;Virpi Leppa;Anna-Maija Kristiina Sulonen;Anna-Maija Kristiina Sulonen;Teppo Varilo;Teppo Varilo

  287
  Citations

• Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder : differential involvement of immune-related gene loci

  O A Andreassen;O A Andreassen;O A Andreassen;H F Harbo;Y Wang;W K Thompson

  217
  Citations

• DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis

  Lara Kular;Yun Liu;Yun Liu;Sabrina Ruhrmann;Galina Zheleznyakova

  209
  Citations

• CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis.

  Harbo Hf;Celius Eg;Vartdal F;Spurkland A

  197
  Citations

• Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.

  Peter K. Gregersen;Roman Kosoy;Annette T. Lee;Janine Lamb

  194
  Citations

• Altered ovarian function and cardiovascular risk factors in valproate-treated women

  Jouko I.T Isojärvi;Erik Taubøll;Arto J Pakarinen;Johan van Parys

  186
  Citations

• Genes in the HLA class I region may contribute to the HLA class II‐associated genetic susceptibility to multiple sclerosis

  H.F. Harbo;B.A. Lie;S. Sawcer;E.G. Celius

  178
  Citations

• Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor

  Maria Ban;An Goris;Åslaug R. Lorentzen;Amie Baker

  171
  Citations

• Network-based multiple sclerosis pathway analysis with GWAS data from 15,000 cases and 30,000 controls

  Sergio E. Baranzini;Pouya Khankhanian;Nikolaos A. Patsopoulos;Michael Li

  165
  Citations

• The expanding genetic overlap between multiple sclerosis and type I diabetes

  David R Booth;Robert N Heard;Graeme J Stewart;An Goris

  155
  Citations

• Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis

  E.G Celius;H.F Harbo;T Egeland;F Vartdal

  155
  Citations

• Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian population

  Angelina Maniaol;Ahmed Elsais;Ahmed Elsais;Åslaug Rudjord Lorentzen;Jone Furulund Owe

  144
  Citations

• Environmental risk factors in multiple sclerosis.

  Maura Pugliatti;Maura Pugliatti;Hanne Flinstad Harbo;Trygve Holmøy;Margitta T. Kampman

  136
  Citations